Bosentan Therapeutic StudiesSafety Database
Therapeutic StudiesN = 972
BC15064/part I1000 mg/dOL (n = 7)
NC154621000 mg/dPC, DB (n = 370)
BC15064/part II2000 mg/dPC, DB (n = 36)
NC150182000 mg/dPC, DB (n = 34)
NC15020100-2000 mg/dPC, DB (n = 243)
BD148842000 mg/dPC, DB (n = 7)
AC-052-351250 mg/dPC, DB (n = 32)
ENABLE250 mg/dPC, DB (n = 1613)
AC-052-353250 mg/dOL (n = 29)
AC-052-352250/500 mg/dPC, DB (n = 213)
AC-052-354250 mg/dOL (n = 200)